Related Experiment Video
Updated: Jun 12, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain
Erica Buoso1, Cristina Lanni, Gennaro Schettini
1Department of Experimental and Applied Pharmacology, Center of Excellence in Applied Biology, University of Pavia, Viale Taramelli 14, 27100 Pavia, Italy.
Abstract:
Alzheimer's disease (AD) is a neurodegenerative disorder that represents the most common type of dementia in the elderly. One of the hallmarks of this disease is a progressive accumulation of amyloid fibrils in senile plaques (SPs), which are composed principally of amyloid-beta peptides (Abeta). The 4-kDa beta-amyloid peptides are produced from the beta-amyloid precursor protein (APP) through sequential processing by beta- and gamma-secretase enzymes in the amyloidogenic pathway. By an alternative non-amyloidogenic pathway, mediated by alpha- and gamma-secretases enzymes, APP is processed within the Abeta domain. Both processing pathways may result in the generation of a fragment called APP intracellular C-terminal domain (AICD) which is hypothesized to contribute to the pathophysiology of AD. Experimental evidence highlights that biological functions of AICD are mediated by interactions between its YENPTY motif and specific binding factors. We critically reviewed literature concerning physiological function of this proteolitic fragment, mainly focusing on their degradation by the two best characterized systems, proteasome and IDE (insulin degrading enzyme). Our work is aimed to analyse the functional role of AICD, integrating also the AICD degradation processes, to better define a potential role of AICD in signal transduction.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Alzheimer Disease ll: Pathophysiology
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...

